Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Nanomedicine. 2015 Aug 15;11(8):1925–1938. doi: 10.1016/j.nano.2015.07.012

Figure 7. Effects of Cremophor-EL on peroxisome proliferation.

Figure 7

Human PBMCs were treated with 12.5 μM of Cremophor-EL for 18 h prior to analysis of intracellular levels of PMP-70 by flow cytometry. Dotted line – isotype control; hatched filled histogram – NC; solid line – Cremophor-EL. Shown is the representative data from one of three individual donors.